Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Syntonix Pharmaceuticals, Inc.”

12 pharma patents match "Syntonix Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Syntonix Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Syntonix Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8815246

    Fc receptor binding proteins

    Syntonix Pharmaceuticals, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  2. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  3. US 8329182

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  4. US 8293707

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity

    Syntonix Pharmaceuticals, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  5. US 8273351

    Fc receptor binding proteins

    Syntonix Pharmaceuticals, Inc. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  6. US 8101186

    Peptides that block the binding of IgG to FcRn

    Syntonix Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  7. US 7862820

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  8. US 7820162

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  9. US 7601516

    Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility

    Syntonix Pharmaceuticals, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  10. US 7404956

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  11. US 7381408

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted

  12. US 7348004

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.